PO-063: Prognostic Values of Inflammation and Immune-based Scores in Patients with Hepatocellular Carcinoma Who Undergo Transarterial Chemoembolization

Aims: We investigated whether baseline inflammation and immune- based scores predict prognosis of hepatocellular carcinoma (HCC) patients treated with transarterial chemoembolization (TACE). Methods: A total of 615 consecutive patients with HCC who had undergone TACE as initial treatment were included from a prospective cohort. The systemic immune inflammation index (SII) defined as (platelet count × neutrophil)/lymphocyte, neutrophil-lymphocyte...